ReviewNature reviews. Clinical oncology2022
Integrated MRI-guided radiotherapy - opportunities and challenges.
Review in Nature reviews. Clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 157 citations in OpenAlex.
- Semi-Automated Image Labeling and Object Tracking for MR-Guided Radiotherapy Using a Foundation Vision Model.Journal of imaging informatics in medicine · 2026Article
- A Review of the Australian MRI Linac Program: From Pie in the Sky to Research Milestone.Journal of medical imaging and radiation oncology · 2026Review
- One-for-All Adaptive Radiotherapy Planning Agent: A Foundation Framework for Daily CBCT-guided Radiotherapy.ArXiv · 2026Article
- Radioactive ion beam range adaptation in mouse tumors using in-beam PET.Communications medicine · 2026Article
- MRI-enhanced online adaptive radiotherapy by virtual integration of a standalone MRI simulator and CBCT-based treatment delivery.Radiation oncology (London, England) · 2026Article
- Towards a shuttle-based workflow for daily online magnetic resonance imaging-guided particle therapy: Anatomical robustness and organ variability in the female pelvis.Technical innovations & patient support in radiation oncology · 2026Article
- Comparison of gantry-less magnetic resonance guided proton therapy with photon therapy for hepatocellular carcinoma patients.Physics and imaging in radiation oncology · 2026Article
- Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases.Journal of neuro-oncology · 2026Article
- Integrative Cross-Modal Fusion of Preoperative MRI and Histopathological Signatures for Improved Survival Prediction in Glioblastoma.Bioengineering (Basel, Switzerland) · 2026Article
- MRI segmentation of head and neck tumors using hybrid attention mechanism and dense dilated spatial pyramid pooling.Journal of applied clinical medical physics · 2026Article
- Generation of multimodal realistic computational phantoms as a test-bed for validating deep learning-based cross-modality synthesis techniques.Medical & biological engineering & computing · 2026Article
- Real-time 4D MRI reconstruction using DVR-NeMF, a framework for dynamic volumetric reconstruction.Cell reports methods · 2025Article
- Evaluation of the Role of Artificial Intelligence-Assisted Diagnosis of Early-Stage Oral Cancer: A Clinical Study.Journal of pharmacy & bioallied sciences · 2025Article
- Deep learning-based synthetic-CT-free photon dose calculation in MR-guided radiotherapy: A proof-of-concept study.Medical physics · 2025Article
- PHSP-Net: Personalized Habitat-Aware Deep Learning for Multi-Center Glioblastoma Survival Prediction Using Multiparametric MRI.Bioengineering (Basel, Switzerland) · 2025Article
- Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation Enteritis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.Nature biotechnology · 2025Article
- Radiotherapy-Activated Prodrug: Past, Present and Beyond.ACS central science · 2025Review
- Research Progress of Persistent Luminescence Nanoparticles in Biological Detection Imaging and Medical Treatment.Materials (Basel, Switzerland) · 2025Review
- A dynamic reconstruction and motion estimation framework for cardiorespiratory motion-resolved real-time volumetric MR imaging (DREME-MR).Physics in medicine and biology · 2025Article
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 5 countries.
Funding
Abstract
MRI can help to categorize tissues as malignant or non-malignant both anatomically and functionally, with a high level of spatial and temporal resolution. This non-invasive imaging modality has been integrated with radiotherapy in devices that can differentially target the most aggressive and resistant regions of tumours. The past decade has seen the clinical deployment of treatment devices that combine imaging with targeted irradiation, making the aspiration of integrated MRI-guided radiotherapy (MRIgRT) a reality. The two main clinical drivers for the adoption of MRIgRT are the ability to image anatomical changes that occur before and during treatment in order to adapt the treatment approach, and to image and target the biological features of each tumour. Using motion management and biological targeting, the radiation dose delivered to the tumour can be adjusted during treatment to improve the probability of tumour control, while simultaneously reducing the radiation delivered to non-malignant tissues, thereby reducing the risk of treatment-related toxicities. The benefits of this approach are expected to increase survival and quality of life. In this Review, we describe the current state of MRIgRT, and the opportunities and challenges of this new radiotherapy approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.